Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune...

por Haist, Maximilian, Stege, Henner, Pemler, Saskia, Heinz, Jaqueline, Fleischer, Maria Isabel, Graf, Claudine, Ruf, Wolfram, Loquai, Carmen, Grabbe, Stephan
Publicado 2021

Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

por Wehler, Thomas C., Graf, Claudine, Möhler, Markus, Herzog, Jutta, Berger, Martin R., Gockel, Ines, Lang, Hauke, Theobald, Matthias, Galle, Peter R., Schimanski, Carl C.
Publicado 2013

Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

por Wehler, Thomas C., Graf, Claudine, Möhler, Markus, Herzog, Jutta, Berger, Martin R., Gockel, Ines, Lang, Hauke, Theobald, Matthias, Galle, Peter R., Schimanski, Carl C.
Publicado 2013

Strong Expression of Chemokine Receptor CXCR4 by Renal Cell Carcinoma Correlates with Advanced Disease

por Wehler, Thomas C., Graf, Claudine, Biesterfeld, Stefan, Brenner, Walburgis, Schadt, Jörg, Gockel, Ines, Berger, Martin R., Thüroff, Joachim W., Galle, Peter R., Moehler, Markus, Schimanski, Carl C.
Publicado 2008

Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy

por Wehler, Thomas C., Hamdi, Swaantje, Maderer, Annett, Graf, Claudine, Gockel, Ines, Schmidtmann, Irene, Hainz, Michael, Berger, Martin R., Theobald, Matthias, Galle, Peter R., Moehler, Markus, Schimanski, Carl C.
Publicado 2012